Mallinckrodt, FTC And The Antitrust Risks Of Pipeline Acquisitions

Acthar case could discourage firms looking to enhance franchises by acquiring drugs in development after FTC alleges firm purchased a would-be competitor to keep it off the US market. Is this something else we can blame on Martin Shkreli?